Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 2 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

0
Player Avatar SorrySam (73.24) Submitted: 3/19/2011 12:25:26 AM : Outperform Start Price: $1.69 THLD Score: +300.24

insider buying

Featured Broker Partners


Advertisement